BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oral Pathology 360 - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oralpathology360.com
X-WR-CALDESC:Events for Oral Pathology 360
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20230221T173000
DTEND;TZID=Asia/Kolkata:20230221T183000
DTSTAMP:20260529T012648
CREATED:20230202T113704Z
LAST-MODIFIED:20230228T131540Z
UID:2644-1677000600-1677004200@oralpathology360.com
SUMMARY:IARC Perspective on Oral Cancer Prevention
DESCRIPTION:Time converter at worldtimebuddy.comTime converter at worldtimebuddy.com\n\n\n\n\n\n\n\n\n\nAbout the lecture:\n\n\n\n\n\n\n\nOral cancer is a significant health concern\, ranking as the 16th most common cancer in the world in 2020. As health professionals\, it’s crucial to stay informed about effective strategies for preventing and managing this disease. \n\n\n\nAccording to a panel of experts at the International Agency for Research on Cancer\, there is strong evidence to suggest that smoking\, areca nut (with and without tobacco)\, and heavy alcohol consumption are significant risk factors for oral cancer. Therefore\, as health professionals\, we must educate our patients about the dangers of these habits and encourage them to quit. Furthermore\, behavioural intervention has been found to be effective in helping adults quit smokeless tobacco\, and we should consider incorporating such interventions into our practice. \n\n\n\nEarly detection is also vital in managing oral cancer. Group *B evidence suggests screening high-risk individuals through clinical oral examination can reduce mortality rates from oral cancer. As health professionals\, we should prioritize identifying patients who may be at risk for prompt and regular screening. \n\n\n\nAs health professionals\, we have a crucial role to play in preventing and managing this disease\, and this session will equip us with the knowledge and tools we need to do so effectively. By attending this session\, you will learn about the following details on Oral Cancer.  \n\n\n\n\n\n\n\n\n\n\n\nPrevention\n\n\n\n\n\n\n\nPrimary & Secondary Strategies for prevention- including risk factor identification\n\n\n\n\n\n\n\n\n\nEarly Detection\n\n\n\n\n\n\n\nEarly detection of potentially malignant disorders \n\n\n\n\n\n\n\n\n\nCessation\n\n\n\n\n\n\n\n Effective cessation strategies\n\n\n\n\n\n\n\n*Read about  Levels and Grades of Evidence • LITFL • CCC Research \n\n\n\n\n\n\n\n\n\nDr Ravi Mehrotra MD\n\n\n\nMember\, Scientific Council IARC – International Agency for Research on Cancer / World Health Organization & Founder\, Centre for Health\, Innovation and Policy FoundationDr Mehrotra is passionate about preventing cancer.As a Physician-Scientist\, his expertise covers the gamut of diagnostics\, epidemiology\, and prevention. He is a Director of the Indian Cancer Genome Atlas\, an Affiliate Investigator at the Division of Public Health Sciences Cancer Prevention Program\, Fred Hutchinson Cancer Center\, Seattle\, WA\, and an  Adjunct Professor at the Emory. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr BEATRICE LAUBY-SECRETAN\n\n\n\nDr Lauby-Secretan obtained her PhD in Toxicology from St Bartholomew & the Royal London School of Medicine and Dentistry in London\, UK. Her research focused on carcinogenesis’s molecular and cellular aspects during her several positions as post-doctoral scientists in London\, UK\, Boston and Los Angeles\, USA\, and Lyon\, France. In 2022\, she joined the IARC Monographs Programme\, where she gained expertise in exposure assessment and observational epidemiology to complement her expertise in experimental research. She also contributed significantly to the IARC Handbooks of Cancer Prevention Programme during that period.Since 2014\, she has been responsible for relaunching and developing the IARC Handbooks of Cancer Prevention Programme. The Handbooks provide comprehensive reviews and consensus evaluation of interventions and strategies to reduce cancer incidence or mortality. The topics reviewed cover both primary and secondary prevention. Further information is available on the IARC Handbooks website at https://handbooks.iarc.fr/.Dr Lauby-Secretan was nominated Head of the IARC Handbooks Programme in August 2017 and is Deputy Head of the Evidence Synthesis and Classification Branch.
URL:https://oralpathology360.com/event/iarc-perspective-on-oral-cancer-prevention/
LOCATION:Oral Pathology 360- YouTube Channel
CATEGORIES:Oral Pathology Tuesdays
ATTACH;FMTTYPE=image/jpeg:https://oralpathology360.com/wp-content/uploads/2023/02/web-featured.jpg
END:VEVENT
END:VCALENDAR